4554 — Fuji Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual cashflow statement for Fuji Pharma Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,961	2,918	3,371	3,723	4,399
Depreciation
Amortisation
Non-Cash Items	-87	-216	497	-175	-556
Unusual Items
Other Non-Cash Items
Changes in Working Capital	1,031	1,010	19	-6,952	-4,947
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	7,034	5,769	5,993	-659	1,919
Capital Expenditures	-3,284	-2,615	-3,896	-12,423	-3,897
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-8,740	-1	1,551	1,152	-1,343
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-12,024	-2,616	-2,345	-11,271	-5,240
Financing Cash Flow Items	-1	-1	-2	-1	-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	7,265	450	-5,435	5,094	1,915
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2,243	3,547	-1,842	-6,653	-1,221